A study to see the efficacy of pyriformis injection wth local anaesthetic plus steroids for management of pyriformis syndrome.
- Conditions
- Health Condition 1: null- Pyriformis syndrome
- Registration Number
- CTRI/2017/08/009223
- Lead Sponsor
- ESI Institute of Pain Management ESI Hospital Sealdah
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
i. Pain -unilateral hip and/or leg pain with positive FAIR (flexion, adduction, internal rotation) test
ii. Tenderness and/or trigger point at the Pyriformis Muscle
iii. Pain unresponsive to conservative treatment like pharmacotherapy with nonsteroidal anti-inflammatory drugs, muscle relaxants, and neuropathic pain agents and physical therapy, which includes stretching of the pyriformis Muscle to correct the underlying pathology
i. Uncontrolled hypertension , uncontrolled diabetes mellitus
ii. Patients having a neurological deficiency
iii. Surgery involving lumbar and/ or hip region
iv. History of allergic reaction to the drug and contrast agent to be used
v. Patient on anticoagulant
vi. History of inflammatory or infectious disease
vii. Non-compensated chronic heart/liver/renal deficiency
viii. Vascular/tumoral disease.
ix. Gestational or lactational period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain using Numerical Rating Score (NRS) on a scale of 1-10Timepoint: Just before the injection and one hour, one week and three weeks after giving the injection
- Secondary Outcome Measures
Name Time Method Back Disability using the roland morris disability questionnaire on a scale of 0-24.Timepoint: Just before the injection and one hour, one week and three weeks after giving the injection